26 results
SC 13D/A
EX-3
10X Fund, L.P.
1 Dec 23
GALECTIN THERAPEUTICS / 10X Fund ownership change
4:38pm
10-K
2022 FY
EX-3.7
GALT
Galectin Therapeutics Inc
Annual report
30 Mar 23
7:52am
8-K
EX-3.2
GALT
Galectin Therapeutics Inc
19 May 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
GALT
Galectin Therapeutics Inc
19 May 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.3
GALT
Galectin Therapeutics Inc
19 May 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
dcu93fxv6ab
17 Feb 17
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-3.1
88z6c1wc3 2xpkid
27 Sep 16
Galectin Therapeutics Announces Top-Line Data from Exploratory Phase 2a Pilot Trial (NASH-FX) with GR-MD-02 in NASH Patients with Advanced Fibrosis
12:00am
8-K
EX-3.1
r7e1w 3e22td
30 May 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-3.2
0tlt3 ff3t
30 May 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-3.1
a5f4p cur2hr00dwi8
23 Mar 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.2
nm8s uo26
2 Jun 11
Judge Paul Pressler Elected to the Board of Directors
12:00am
8-K
EX-3.1
cxpzy
2 Jun 11
Judge Paul Pressler Elected to the Board of Directors
12:00am
8-K
EX-3.3
3mat4gr azek0c1
2 Jun 11
Judge Paul Pressler Elected to the Board of Directors
12:00am
8-K
EX-3.1
2sump95m
27 Jan 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
6mgexahi321vfk0xv
6 Jan 11
Pro-pharmaceuticals Closes $2.1 Million Offering
12:00am
8-K
EX-3.1
vowx0ybchnm
17 Feb 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3.1
vngvggk
28 May 09
Departure of Directors or Certain Officers
12:00am